XML 36 R30.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Operating Segments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2014
Segment Reporting [Abstract] |
Reportable Segments Summarized Financial Information | Summarized financial information concerning our reportable segments is shown in the following table. Results for 2013 have been recast to reflect the change in operating segments noted above, and segment results for all periods presented exclude discontinued operations as further described in Notes 1 and 15. Corporate & other includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to each segment whereas the remaining components of pension and OPEB benefits cost or credit are included in Corporate & other.
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2014 |  | 2013 |  | 2014 |  | 2013
| (In thousands)
Net sales: |  |  |  |  |  |  |
Performance Chemicals | $ | 364,517 |  |  | $ | 365,154 |  |  | $ | 1,048,961 |  |  | $ | 1,059,202 |
Catalyst Solutions | 277,901 |  |  | 226,042 |  |  | 798,021 |  |  | 695,433 |
Total net sales | $ | 642,418 |  |  | $ | 591,196 |  |  | $ | 1,846,982 |  |  | $ | 1,754,635 |
Segment operating profit: |  |  |  |  |  |  |
Performance Chemicals | $ | 86,983 |  |  | $ | 91,506 |  |  | $ | 244,724 |  |  | $ | 265,665 |
Catalyst Solutions | 53,039 |  |  | 47,205 |  |  | 162,169 |  |  | 125,615 |
Total segment operating profit | 140,022 |  |  | 138,711 |  |  | 406,893 |  |  | 391,280 |
Equity in net income of unconsolidated investments: |  |  |  |  |  |  |
Performance Chemicals | 1,744 |  |  | 1,735 |  |  | 7,321 |  |  | 6,371 |
Catalyst Solutions | 6,906 |  |  | 3,603 |  |  | 20,879 |  |  | 18,937 |
Total equity in net income of unconsolidated investments | 8,650 |  |  | 5,338 |  |  | 28,200 |  |  | 25,308 |
Net income attributable to noncontrolling interests: |  |  |  |  |  |  |
Performance Chemicals | (8,546 | ) |  | (7,332 | ) |  | (23,130 | ) |  | (21,250 | )
Total net income attributable to noncontrolling interests | (8,546 | ) |  | (7,332 | ) |  | (23,130 | ) |  | (21,250 | )
Segment income: |  |  |  |  |  |  |
Performance Chemicals | 80,181 |  |  | 85,909 |  |  | 228,915 |  |  | 250,786 |
Catalyst Solutions | 59,945 |  |  | 50,808 |  |  | 183,048 |  |  | 144,552 |
Total segment income | 140,126 |  |  | 136,717 |  |  | 411,963 |  |  | 395,338 |
Corporate & other(a) | (22,995 | ) |  | (9,909 | ) |  | (76,528 | ) |  | (41,715 | )
Restructuring and other charges, net | (293 | ) |  | — |  |  | (20,625 | ) |  | — |
Acquisition and integration related costs | (10,261 | ) |  | — |  |  | (15,104 | ) |  | — |
Interest and financing expenses | (8,749 | ) |  | (9,496 | ) |  | (26,255 | ) |  | (22,335 | )
Other expenses, net | (6,618 | ) |  | (368 | ) |  | (6,454 | ) |  | (6,147 | )
Income tax expense | (11,737 | ) |  | (26,963 | ) |  | (46,700 | ) |  | (72,897 | )
(Loss) income from discontinued operations (net of tax) | (6,679 | ) |  | 531 |  |  | (68,473 | ) |  | 4,994 |
Net income attributable to Albemarle Corporation | $ | 72,794 |  |  | $ | 90,512 |  |  | $ | 151,824 |  |  | $ | 257,238 |
(a) | For the three months ended September 30, 2014 and 2013, Corporate & other includes $(1.9) million and $1.0 million, respectively, of pension and OPEB plan (costs) credits, and for the nine months ended September 30, 2014 and 2013, Corporate & other includes $(15.7) million and $3.1 million, respectively, of pension and OPEB plan (costs) credits.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration